REG - MyCelx Tech. Corp. MyCelx Tech. Corp.. - Appointment of CFO/Grant of Share Options <Origin Href="QuoteRef">MYXR.L</Origin>

Mycelx TechnologiesAnnouncement

16/03/2016 07:00

RNS Number : 2166S
MyCelx Technologies Corporation
15 March 2016
MYCELX Technologies Corporation 
("MYCELX" or the "Company") (AIM: MYX)
16 March 2016
Appointment of Chief Financial Officer
The Company announces that Kimberly Slayton, formerly Interim Chief Financial Officer, has been appointed as Chief Financial Officer with immediate effect.
Grant of Share Option to Chief Financial Officer
On 14 March 2016 Ms. Slayton was awarded the following options over the Company's common shares of US$0.025 each ("Common Shares") under the MYCELX Omnibus Performance Incentive Plan ("Plan"):
Name of Director
Number of share options granted
Exercise price
Total number of share options held following this notification
Total number of share options as % of current issued share capital
Kimberly Slayton 
70,000
US$0.40*
100,000
0.53%
Ms. Slayton holds no Common Shares in the issued capital of the Company.
Grant of Share Option to Chief Business Development Officer
The Company further announces that Mark Mixon, Chief Business Development Officer, was granted an option on 14 March 2016 under the Plan over 65,000 Common Shares. The grant to Mr. Mixon was as follows:
Name 
Number of share options granted
Exercise price
Total number of share options held following this notification
Total number of share options as % of current issued share capital
Mark Mixon 
65,000
US$0.40*
265,204
1.41%
In addition, following this transaction, Mr. Mixon continues to be interested in 10,000 Common Shares, representing 0.05 per cent of the present issued capital of the Company, which he holds as a custodian.
Following this award, Connie Mixon, Chief Executive Officer and spouse of Mr. Mixon is interested in an aggregate (including the interests of Mr. Mixon) of 991,210 Common Shares, representing 5.28 per cent of the present issued capital of the Company, and in options over an aggregate (including the interests of Mr. Mixon) of 428,221 Common Shares, representing 2.28 per cent of the present issued capital of the Company. 
The aggregate number of Common Shares held by Ms. Mixon also includes (a) 150,000 shares held by limited liability companies controlled by Ms. Mixon; and (b) 202,646 shares held by or on behalf of Ms. Mixon's children.
The above grants formed part of wider grants of 370,000 options to employees across the Company, on the same date, representing 1.97% of the current issued share capital. 
The share options granted on 14 March 2016 will vest as to 50% on 31 December 2016 and 50% on 31 December 2017, and must be exercised prior to the tenth anniversary of the date of grant, subject to the restrictions on dealing under the Company's share dealing code. 
*Based on the mid-market closing price of the Company's Common Shares at 11 March 2016, and the closing US/ exchange rate at that date.
For further information please contact:
MYCELX Technologies Corporation
Connie Mixon, CEO
Kimberly Slayton, CFO
Tel: +1 888 306 6843
RFC Ambrian Limited 
Corporate Finance
Samantha Harrison
Jonathan Stephens
Corporate Broking
Jonathan Williams
Kim Eckhof
Tel: +44 20 3440 6800
Numis Securities Limited 
Corporate Broking
James Black
Ben Stoop
Tel: +44 20 7260 1000
Bell Pottinger
Nick Lambert
Henry LerwillTel: +44 20 3772 2500

This information is provided by RNS
The company news service from the London Stock Exchange
  END
RDSEADDSFFAKEAF